International Journal of Hypertension
Scope & Guideline
Empowering researchers to combat hypertension globally.
Introduction
Aims and Scopes
- Clinical Research on Hypertension Treatments:
The journal publishes extensive clinical research focusing on various treatment approaches for hypertension, including pharmacological and non-pharmacological interventions, as well as studies assessing the efficacy and safety of antihypertensive medications. - Epidemiological Studies and Risk Factors:
A significant portion of articles explores the epidemiology of hypertension, identifying risk factors, prevalence, and demographic variables influencing hypertension across different populations globally. - Genetic and Molecular Mechanisms:
Research highlighting genetic polymorphisms, molecular pathways, and biochemical markers related to hypertension is a consistent focus, contributing to the understanding of individual susceptibility and disease mechanisms. - Lifestyle and Behavioral Studies:
The journal includes studies examining the impact of lifestyle factors such as diet, physical activity, and psychosocial influences on hypertension management and outcomes, emphasizing holistic approaches to care. - Innovative Diagnostic and Predictive Tools:
Papers often discuss new diagnostic methods and predictive models for hypertension, contributing to improved risk assessment and management strategies in clinical settings.
Trending and Emerging
- Pharmacogenomics and Personalized Medicine:
Increasingly, studies are focusing on pharmacogenomics, exploring how genetic variations affect individual responses to antihypertensive medications, thereby paving the way for personalized treatment plans. - Hypertension and Comorbid Conditions:
There is a growing trend in research examining the interplay between hypertension and comorbidities such as diabetes, obesity, and mental health disorders, highlighting the need for integrated care approaches. - Impact of Environmental Factors:
Emerging research is increasingly investigating the effects of environmental factors, including pollution and climate change, on hypertension prevalence and management, reflecting a broader understanding of public health influences. - Digital Health and Telemedicine:
The integration of digital health technologies and telemedicine in hypertension management is gaining traction, as studies explore their effectiveness in improving patient outcomes and adherence to treatment. - Global Health Perspectives:
An emphasis on global health perspectives, including studies that address hypertension in low- and middle-income countries, is rising, reflecting the journal's commitment to understanding hypertension in diverse contexts.
Declining or Waning
- Traditional Dietary Factors:
Research focusing on traditional dietary factors such as salt intake and its direct correlation with hypertension has become less frequent, likely overshadowed by studies exploring more complex dietary patterns and their metabolic impacts. - Surgical Interventions for Hypertension:
There has been a noticeable decrease in studies focusing on surgical interventions for hypertension, such as renal denervation, as interest shifts towards less invasive and more pharmacological approaches. - Single-Country Epidemiological Studies:
The prevalence of single-country epidemiological studies has waned, possibly due to a growing emphasis on multinational and cross-cultural studies that provide broader insights into hypertension management globally. - Basic Science Studies:
While foundational research remains important, basic science studies focusing solely on laboratory findings without clinical implications have seen a decline, as the journal prioritizes translational research that bridges laboratory findings to clinical practice.
Similar Journals
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
Bridging Research and Clinical Practice in RAASJOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, published by SAGE PUBLICATIONS INC, stands as a vital resource in the fields of Endocrinology and Internal Medicine. With an impressive open access model established in 2014, this journal facilitates broad dissemination of high-quality research that explores the complex mechanisms and clinical implications of the renin-angiotensin-aldosterone system (RAAS). Currently, it is recognized within the 2023 Category Quartiles as Q3 in Endocrinology and Q2 in Internal Medicine, reflecting its significant impact on the scientific community. The journal ranks in the 75th percentile for Internal Medicine and the 57th percentile in Endocrinology according to Scopus, indicating its strong contributions to these disciplines. Covering a rich history from its inception in 2000 to the present, the journal aims to bridge the gap between basic research and clinical practice, thereby enhancing the understanding and treatment of conditions influenced by RAAS. The continuous publication of innovative research makes it an essential reference for researchers, healthcare professionals, and students engaged in these dynamic fields.
JOURNAL OF HUMAN HYPERTENSION
Pioneering research that bridges science and clinical practice.JOURNAL OF HUMAN HYPERTENSION, a prominent publication in the field of internal medicine, is dedicated to advancing the understanding of hypertension and its implications for human health. Published by SPRINGERNATURE in the United Kingdom, this esteemed journal has been a vital resource for researchers and clinicians since its inception in 1987, with a continuous commitment to disseminating high-quality, peer-reviewed research. With an impressive Q2 category rank in Internal Medicine and a Scopus rank of 53 out of 167, it occupies a crucial position within the academic community, reaching a 68th percentile ranking that underscores its significance. The journal aims to provide a platform for innovative studies and reviews, fostering knowledge that bridges basic science, clinical practice, and public health. Although it does not currently offer open access, it remains accessible through institutional subscriptions, ensuring that vital information about hypertension is available to a broad spectrum of healthcare professionals and researchers. Explore the critical findings and groundbreaking research published in the JOURNAL OF HUMAN HYPERTENSION to stay at the forefront of hypertension studies.
Clinica e Investigacion en Arteriosclerosis
Driving excellence in the understanding of cardiovascular diseases.Clinica e Investigacion en Arteriosclerosis is a premier academic journal dedicated to the field of cardiology and cardiovascular medicine, published by ELSEVIER. With its ISSN 0214-9168 and E-ISSN 1578-1879, the journal aims to disseminate high-quality research and innovations in the understanding and treatment of arterial diseases, contributing significantly to both clinical practices and pharmacological advancements. Established in 2007 and continuing into 2024, the journal has garnered recognition with a notable Q3 categorization in both Cardiology and Cardiovascular Medicine and Pharmacology (medical) for 2023, reflecting its impact in the academic community. Researchers and healthcare professionals utilizing this journal will find a diverse range of articles exploring novel therapeutic strategies and epidemiological data, making it an essential resource for advancing knowledge and practice in cardiovascular health. While it does not operate as an open-access journal, the findings published in Clinica e Investigacion en Arteriosclerosis are pivotal for understanding current trends and future directions in cardiovascular research.
CLINICAL AND EXPERIMENTAL HYPERTENSION
Innovating treatment strategies for hypertension.Clinical and Experimental Hypertension, published by Taylor & Francis Inc, is a crucial resource in the fields of internal medicine and physiology. With its inaugural publication dating back to 1978, this esteemed journal has successfully merged decades of research, providing a platform for the latest advancements in hypertension studies. Operating without an open access model, it is configured to serve a specialized audience of researchers, clinicians, and students who are dedicated to exploring innovative treatment modalities and understanding the complexities of hypertensive diseases. Ranked in the Q3 category in both Internal Medicine and Physiology, this journal accomplishes a commendable standing in the academic community, exemplified by its Scopus rankings which position it within the median percentile range in its field. By disseminating high-quality research and fostering scientific dialogue, Clinical and Experimental Hypertension plays a pivotal role in shaping contemporary understanding and clinical practices concerning hypertension management.
BLOOD PRESSURE
Advancing cardiovascular health through innovative research.BLOOD PRESSURE is a distinguished journal published by Taylor & Francis Ltd in the field of cardiology and internal medicine, with an ISSN of 0803-7051 and E-ISSN of 1651-1999. Since its inception in 1992, it has become a vital source of research and clinical information, dedicated to advancing our understanding of blood pressure-related health issues. With a notable categorization of Q3 in Cardiology and Cardiovascular Medicine and Q2 in Internal Medicine as of 2023, this journal exemplifies a commitment to evidence-based findings that impact clinical practice and patient care. The journal facilitates a platform for original research, reviews, and case studies, aiming to bridge the gap between researchers and practitioners. Although it does not currently offer open access, BLOOD PRESSURE remains an essential resource for professionals and students alike, striving to enhance health outcomes through dedication to innovative cardiovascular research.
JOURNAL OF HYPERTENSION
Driving innovation in hypertension management and treatment.JOURNAL OF HYPERTENSION, published by Lippincott Williams & Wilkins, stands at the forefront of cardiovascular research, serving as a premier platform for the dissemination of knowledge in hypertension and related cardiovascular conditions. With an impressive impact factor, this esteemed journal is recognized in Q1 quartile across multiple categories, including Cardiology, Internal Medicine, and Physiology as of 2023, firmly establishing its significance within the academic community. The journal has been a reliable source of cutting-edge research since its inception in 1983, with continued publication through 2024. Researchers can expect a rigorous peer-review process and a diverse array of articles that include original research, reviews, and clinical studies aimed at enhancing the understanding and management of hypertension. Although it is not an open-access journal, the JOURNAL OF HYPERTENSION remains invaluable to clinicians, researchers, and students dedicated to advancing the field of cardiovascular health.
HYPERTENSION RESEARCH
Exploring innovative strategies in hypertension management.HYPERTENSION RESEARCH, published by SpringerNature, serves as a premier platform in the field of Cardiology and Cardiovascular Medicine, Internal Medicine, and Physiology. Since its inception in 1992, the journal has built a substantial reputation, currently ranked in the second quartile (Q2) across several categories in 2023, reflecting its influence and high-quality contributions to medical research. With a focus on hypertension, the journal aims to disseminate vital research findings, clinical studies, and innovative treatment strategies to a diverse audience of researchers, healthcare professionals, and students, fostering knowledge exchange in the management of hypertensive conditions. Although it is not an Open Access journal, it offers comprehensive access to its extensive archive of valuable resources, ensuring that critical advancements in the understanding of hypertension are both accessible and impactful. HYPERTENSION RESEARCH is not only essential for those directly involved in cardiovascular and internal medicine practices but also for interdisciplinary scholars who are looking to explore the intersections of physiology and other biomedical fields in their work.
HYPERTENSION IN PREGNANCY
Advancing Research for Safer PregnanciesHYPERTENSION IN PREGNANCY is a leading academic journal dedicated to the critical study of hypertensive disorders during pregnancy, a crucial area of maternal and fetal health. Published by Taylor & Francis Inc, this journal boasts an Open Access policy since 2023, ensuring that research findings are freely accessible to a global audience. With an ISSN of 1064-1955 and E-ISSN of 1525-6065, it offers a platform for high-quality research and review articles since its inception in 1982. The journal holds a Q3 category ranking in both Internal Medicine and Obstetrics and Gynecology, reflecting its reputable standing within the scientific community. As of 2023, it ranks among the top quartile publications in its field, with Scopus ranking it 86/209 in Obstetrics and Gynecology and 83/167 in Internal Medicine. This journal aims to foster dialogue among researchers, clinicians, and policymakers regarding the management and implications of hypertension in pregnancy, promoting advancements in care and research methodologies. Located in Philadelphia, PA, it continues to be an invaluable resource for those invested in improving maternal health outcomes and advancing the field.
CURRENT HYPERTENSION REPORTS
Exploring the complexities of cardiovascular health.CURRENT HYPERTENSION REPORTS is a premier journal dedicated to advancing the field of cardiovascular health, particularly focusing on hypertension and its multifaceted implications. Published by SPRINGER, this influential journal boasts an impressive impact factor and ranks in the top Q1 category among Internal Medicine journals, placing it within the elite 88th percentile of its field according to Scopus rankings. Since its inception in 1999, it has provided a platform for cutting-edge research and clinical insights, facilitating knowledge exchange among researchers, healthcare professionals, and students alike. With a commitment to publishing high-quality articles without open access barriers, CURRENT HYPERTENSION REPORTS remains an essential resource for those looking to stay abreast of the latest developments and trends in hypertension management and treatment.
Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health
Exploring the Intersection of Pregnancy and Cardiovascular WellnessPregnancy Hypertension – An International Journal of Women's Cardiovascular Health, published by Elsevier Science Ltd, is a leading platform dedicated to advancing the understanding of cardiovascular health in women during pregnancy and postpartum periods. With an ISSN of 2210-7789, this esteemed journal has distinguished itself in the fields of Internal Medicine and Obstetrics and Gynecology, maintaining a remarkable Q2 ranking in Internal Medicine and a prestigious Q1 ranking in Obstetrics and Gynecology as of 2023. It is recognized for its high-quality research, which fits within the top quartile of its categories, and spans from 2010 to 2024, reflecting its ongoing contribution to critical advancements in women's cardiovascular health. The journal is accessible to a global audience of researchers, practitioners, and students, emphasizing its commitment to promoting open scholarly communication, although it currently operates under traditional access. The publication serves as a crucial resource for those seeking to enhance their knowledge and practices related to the unique cardiovascular challenges faced by women during pregnancy, thereby fostering informed clinical approaches and improved health outcomes.